CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-09 | Ho Carole Chief Medical Officer | Sale | −1,423 | $37.10 | $53K | 166,112 |
| 2022-02-03 | Harris Erik Director | Grant or award | +6,869 | 6,869 | ||
| 2022-02-03 | Harris Erik Director | Grant or award · Stock Option (right to buy) | +20,607 | 20,607 | ||
| 2022-01-08 | Thornberry Nancy Director | Grant or award | +627 | 2,511 | ||
| 2022-01-05 | Watts Ryan J. President and CEO | Sale | −5,007 | $44.78 | $224K | 2,113,361 |
| 2022-01-05 | Krognes Steve E. CFO and Treasurer | Sale | −2,225 | $44.75 | $100K | 124,077 |
| 2022-01-05 | Ho Carole Chief Medical Officer | Sale | −2,845 | $44.78 | $127K | 163,285 |
| 2022-01-05 | Schuth Alexander O. COO and Secretary | Sale | −2,846 | $44.77 | $127K | 457,737 |
| 2022-01-03 | Schuth Alexander O. COO and Secretary | Grant or award | +31,000 | 117,454 | ||
| 2022-01-03 | Schuth Alexander O. COO and Secretary | Grant or award · Stock Option (right to buy) | +93,000 | 93,000 | ||
| 2022-01-03 | Ho Carole Chief Medical Officer | Grant or award | +31,000 | 107,316 | ||
| 2022-01-03 | Ho Carole Chief Medical Officer | Grant or award · Stock Option (right to buy) | +93,000 | 93,000 | ||
| 2022-01-03 | Watts Ryan J. President and CEO | Grant or award | +62,000 | 213,691 | ||
| 2022-01-03 | Watts Ryan J. President and CEO | Grant or award · Stock Option (right to buy) | +186,500 | 186,500 | ||
| 2022-01-03 | Krognes Steve E. CFO and Treasurer | Grant or award | +31,000 | 126,302 | ||
| 2022-01-03 | Krognes Steve E. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +93,000 | 93,000 | ||
| 2021-12-30 | Tessier-Lavigne Marc Director | Sale | −3,343 | $45.13 | $151K | 82,225 |
| 2021-12-30 | Tessier-Lavigne Marc Director | Sale | −3,377 | $45.59 | $154K | 78,848 |
| 2021-12-30 | Tessier-Lavigne Marc Director | Sale | −5,625 | $45.31 | $255K | 80,073 |
| 2021-12-30 | Tessier-Lavigne Marc Director | Sale | −900 | $45.71 | $41K | 79,173 |
Page 17 of 53 · 1,043 trades